Free discreet shipping on every order|Save 10% on $150+ — code WELLNESS10|Save 15% on $300+ — code WELLNESS15|Save 20% on $600+ — code WELLNESS20|Your partner discount is applied at checkout|Free Shipping on $150+ after discounts
Research Use Only. These compounds are intended for laboratory and research purposes. Not for human consumption. Portal to Wellness complies with all applicable regulations.
GLP-1 & Metabolic Research Guide
The Compounds Behind Metabolic Research.
GLP-1 and amylin receptor agonists and related metabolic compounds are described in the published literature by receptor pharmacology. This guide summarises what the published literature reports for each.
Research-Grade MaterialSpecifications listed per product
🇺🇸
US-Based OperationsDomestic sourcing & shipping
📦
Fast, Discreet ShippingShipped within 1–2 business days
💬
Expert SupportOrder and product questions answered
Research Areas
This kit contains compounds studied in the following areas…
✓
Appetite and satiety signalling — the GLP-1, GIP and amylin receptor pathways.
✓
Energy expenditure and lipolysis — glucagon receptor agonism and AOD-9604.
✓
Cellular metabolic regulation — the NNMT pathway targeted by 5-Amino-1MQ.
✓
Insulin sensitivity and glucose handling — the incretin literature.
Why These Compounds Are Studied
GLP-1 and Beyond: The Biology of Metabolic Regulation
GLP-1 receptor agonists like Semaglutide and Tirzepatide have shaped metabolic research: clinical trials of the approved medicines in this class show that appetite, insulin sensitivity and fat metabolism are hormonally regulated systems. Beyond GLP-1, AOD-9604 is studied for its effect on lipolysis, and 5-Amino-1MQ for its inhibition of the NNMT enzyme.
The most studied GLP-1 receptor agonist in metabolic research. It mimics the incretin hormone GLP-1; published studies examine its effects on appetite signalling, gastric emptying and insulin sensitivity.
Top Rated
Dual GIP/GLP-1 Agonist
Tirzepatide — 60mg/vial
A dual agonist targeting both GLP-1 and GIP receptors simultaneously. Head-to-head trials have compared it with single-pathway GLP-1 agonists on body-composition endpoints.
Fat-Targeting Peptide
AOD-9604 — 5mg/vial
A modified fragment of human growth hormone (amino acids 176–191) studied for its effect on lipolysis, without the growth-promoting activity of full-length growth hormone.
Metabolic Enzyme Inhibitor
5-Amino-1MQ — 50mg/vial
Targets NNMT (Nicotinamide N-methyltransferase), an enzyme elevated in adipose tissue that blunts metabolic rate. Preclinical studies of NNMT inhibition examine energy expenditure and adipocyte metabolism in animal models.
Curated Kit
The Metabolic Research Set
The kit groups four compounds studied against four separate mechanisms — incretin signalling, amylin satiety signalling, NAD+ co-enzyme supply and mitochondrial cardiolipin structure. Priced 20% below buying the components separately.
Browse the Metabolic Research category, or start with the most published compound in the class — Semaglutide. Unsure? The Research Hub sets out the published research on each compound.
2
Review the Research
Each product page sets out the mechanism, the specifications and the published research context. Portal to Wellness does not publish protocols or quantities for use.
3
Order
Your order ships within 1–2 business days. Join our affiliate and loyalty program for ongoing savings as you continue your research.
Not sure where to start?
The Research Hub sets out the published research on every compound we carry.
Grouped by receptor target and mechanism of action, to help researchers locate the compounds relevant to a given research question.
🟢 Single & Dual Receptor Agonists
Tirzepatide is a dual GIP + GLP-1 receptor agonist, giving it broader receptor coverage than semaglutide, and it has been more extensively studied for body-composition outcomes. Semaglutide is a single GLP-1 receptor agonist and is the most widely published compound in this class, which makes it a common reference point in the literature.
$116.47Original price was: $116.47.$99.00Current price is: $99.00.— or subscribe to save 10% Add to cart
🔵 Triple Agonists & Amylin Combinations
Retatrutide adds glucagon receptor agonism to the GIP + GLP-1 mechanism, making it a triple agonist; trial data has examined its effect on fat oxidation. The retatrutide + cagrilintide pairing introduces the amylin pathway, and is studied as a multi-target approach in metabolic research.
🔴 Multi-Pathway Combinations
Retatrutide alongside cagrilintide (an amylin analog) and 5-Amino-1MQ (an NNMT inhibitor studied for cellular metabolic reprogramming). These compounds act on distinct pathways and have been examined together in multi-pathway metabolic research.
All compounds sold by Portal to Wellness are intended for research purposes only. Citations are provided for educational context.
Discount Applied Successfully!
Your savings have been added to the cart.
All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
Refund Policy
PTW Research Assistant
Powered by Claude AI · Typically replies instantly
Enter to send · Shift+Enter for new line · For research purposes only
Scroll to Top
All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, human consumption, or veterinary use. Not for human use. Must be 18 years or older to purchase.
